Top compounds associated with response to TMEM261


Feature Type Standardized
Nominal ANOVA
mRNA Gemcitabine GDSC1000 pan-cancer AAC 0.016 0.6
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.6
mRNA etoposide CTRPv2 pan-cancer AAC 0.013 0.7
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC 0.018 0.7
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA Bleomycin GDSC1000 pan-cancer AAC 0.016 0.7
mRNA BRD-K03911514 CTRPv2 pan-cancer AAC 0.024 0.7
mRNA MK 1775 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA DBeQ CTRPv2 pan-cancer AAC -0.016 0.7
Download CSV